China, Nov. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Study on the Early Protective Efficacy of Zamerovimab and Mazorelvimab Injection'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600136265
Registration Time: 2026/11/09
Type: Observational study
Primary Sponsor: Yantaishan Hospital，Yantai
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=318907
Published by HT Digital Content Services with permission from Health Daily Digest....